Get started
Author

Olivier Taboureau

Observed names: O Taboureau, O. Taboureau, Olivier T. Taboureau, TABOUREAU, Olivier, Taboureau O, Taboureau, O., Taboureau, Olivier
Observed institutions: Novozymes (Denmark), University of Copenhagen, Université d'Orléans, Centre National de la Recherche Scientifique, Inserm, University of New Mexico, Novo Nordisk (Denmark), Université Paris Cité, Novo Nordisk Foundation, Sorbonne Paris Cité, Health and Functional Exposomics, Unit of Functional and Adaptive Biology, Université Paris Diderot, Physiologie De L'Axe Gonadotrope, Molécules Thérapeutique in silico, Vrije Universiteit Amsterdam, Technical University of Denmark
ORCID: 0000-0001-7081-2491
Observed ORCID: 0000-0001-7081-2491
OpenAlex ID: A5005294445
Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus
2005 · Per H. Mygind, Rikke L. Fischer, et al. · Nature · 657
Adverse outcome pathways: opportunities, limitations and open questions
2017 · Marcel Leist, Ahmed Ghallab, et al. · Archives of Toxicology · 384
Network‐based Approaches in Pharmacology
2017 · Baptiste Boezio, Karine Audouze, et al. · Molecular Informatics · 363
PDF
CoMPARA: Collaborative Modeling Project for Androgen Receptor Activity
2020 · Kamel Mansouri, Nicole Kleinstreuer, et al. · Environmental Health Perspectives · 208
ChemProt-3.0: a global chemical biology diseases mapping
2016 · Jens Kringelum, Sonny Kim Kjaerulff, et al. · Database · 138
PDF
Temporal Variability in Urinary Phthalate Metabolite Excretion Based on Spot, Morning, and 24-h Urine Samples: Considerations for Epidemiological Studies
2012 · Hanne Frederiksen, Selma K. Kranich, et al. · Environmental Science & Technology · 137
Location of the Antidepressant Binding Site in the Serotonin Transporter
2009 · Jacob Andersen, Olivier Taboureau, et al. · Journal of Biological Chemistry · 123
PDF
Computational investigations of hERG channel blockers: New insights and current predictive models
2015 · Bruno O. Villoutreix, Olivier Taboureau · Advanced Drug Delivery Reviews · 114
Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer‐Aided Drug Repurposing
2011 · Tudor I. Oprea, Sonny Kim Nielsen, et al. · Molecular Informatics · 114
ChemProt: a disease chemical biology database
2010 · O. Taboureau, S. K. Nielsen, et al. · Nucleic Acids Research · 105
PDF
Classification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning Techniques
2008 · Poongavanam Vasanthanathan, Olivier Taboureau, et al. · Drug Metabolism and Disposition · 104
Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin Transporter
2009 · Jacob Andersen, Lars Olsen, et al. · Journal of Biological Chemistry · 100
PDF
hERG Classification Model Based on a Combination of Support Vector Machine Method and GRIND Descriptors
2008 · Qiyuan Li, Flemming Steen Jørgensen, et al. · Molecular Pharmaceutics · 96
Virtual Screening and Prediction of Site of Metabolism for Cytochrome P450 1A2 Ligands
2008 · Poongavanam Vasanthanathan, Jozef Hritz, et al. · Journal of Chemical Information and Modeling · 81
Identification of Odorant-Receptor Interactions by Global Mapping of the Human Odorome
2014 · Karine Audouze, Anne Tromelin, et al. · PLoS ONE · 66
PDF
Established and Emerging Trends in Computational Drug Discovery in the Structural Genomics Era
2012 · Olivier Taboureau, Jonathan B. Baell, et al. · Chemistry & Biology · 63
PDF
ChemProt-2.0: visual navigation in a disease chemical biology database
2012 · Sonny Kim Kjærulff, Louis Wich, et al. · Nucleic Acids Research · 59
Deciphering Diseases and Biological Targets for Environmental Chemicals using Toxicogenomics Networks
2010 · Karine Audouze, Agnieszka Sierakowska Juncker, et al. · PLoS Computational Biology · 59
Evolution of substrate recognition sites (SRSs) in cytochromes P450 from Apiaceae exemplified by the CYP71AJ subfamily
2015 · Bjørn Dueholm, Célia Krieger, et al. · BMC Evolutionary Biology · 56
PDF
Homology Modelling of the GABA Transporter and Analysis of Tiagabine Binding
2010 · Søren Skovstrup, Olivier Taboureau, et al. · ChemMedChem · 56
Association between chemical pattern in breast milk and congenital cryptorchidism: modelling of complex human exposures
2012 · K. Krysiak‐Baltyn, J. Toppari, et al. · International Journal of Andrology · 53
PDF
Country‐specific chemical signatures of persistent environmental compounds in breast milk
2009 · K. Krysiak‐Baltyn, J. Toppari, et al. · International Journal of Andrology · 53
Scientific competency questions as the basis for semantically enriched open pharmacological space development
2013 · Kamal Azzaoui, Edgar Jacoby, et al. · Drug Discovery Today · 48
The impact of network biology in pharmacology and toxicology
2012 · G. Panagiotou, O. Taboureau · SAR and QSAR in environmental research · 46
In Silico Predictions of hERG Channel Blockers in Drug Discovery: From Ligand-Based and Target-Based Approaches to Systems Chemical Biology
2011 · Olivier Taboureau, Flemming Steen Jorgensen · Combinatorial Chemistry & High Throughput Screening · 46
Works count: 152
Citation count: 4,296
H-index: 31
I10-index: 63
Year
Topic
Type